|
1
|
Bernhisel A and Pettey J: Manual small
incision cataract surgery. Curr Opin Ophthalmol. 31:74–79. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Flaxman SR, Bourne R, Resnikoff S, Ackland
P, Braithwaite T, Cicinelli MV, Das A, Jonas JB, Keeffe J, Kempen
JH, et al: Global causes of blindness and distance vision
impairment 1990–2020: A systematic review and meta-analysis. Lancet
Glob Health. 5:e1221–e1234. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kohnen T, Baumeister M, Kook D, Klaproth
OK and Ohrloff C: Cataract surgery with implantation of an
artificial lens. Dtsch Arztebl Int. 106:695–702. 2009.PubMed/NCBI
|
|
4
|
Marques AP, Ramke J, Cairns J, Butt T,
Zhang JH, Jones I, Jovic M, Nandakumar A, Faal H, Taylor H, et al:
The economics of vision impairment and its leading causes: A
systematic review. EClinicalMedicine. 46:1013542022. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
An L, Jan CL, Feng J, Wang Z, Zhan L and
Xu X: Inequity in access: Cataract surgery throughput of chinese
ophthalmologists from the china national eye care capacity and
resource survey. Ophthalmic Epidemiol. 27:29–38. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang XJ, Li EY, Leung CK, Musch DC, Zheng
CR, He MG, Chang DF and Lam DS: Willingness to pay for cataract
surgery in baiyin district, northwestern China. Ophthalmic
Epidemiol. 28:205–212. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rusin-Kaczorowska K and Jurowski P:
Qualification and methods of laser capsulotomy in pseudophakic eye.
Klin Oczna. 114:143–146. 2012.(In Polish). PubMed/NCBI
|
|
8
|
Kaplan HJ: Anatomy and function of the
eye. Chem Immunol Allergy. 92:4–10. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Miesfeld JB and Brown NL: Eye
organogenesis: A hierarchical view of ocular development. Curr Top
Dev Biol. 132:351–393. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cvekl A and Ashery-Padan R: The cellular
and molecular mechanisms of vertebrate lens development.
Development. 141:4432–4447. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schmitt C and Hockwin O: The mechanisms of
cataract formation. J Inherit Metab Dis. 13:501–508. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Thompson J and Lakhani N: Cataracts. Prim
Care. 42:409–423. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
West SK and Valmadrid CT: Epidemiology of
risk factors for age-related cataract. Surv Ophthalmol. 39:323–334.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Straatsma BR, Foos RY, Horwitz J, Gardner
KM and Pettit TH: Aging-related cataract: Laboratory investigation
and clinical management. Ann Intern Med. 102:82–92. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pichi F, Lembo A, Serafino M and Nucci P:
Genetics of congenital cataract. Dev Ophthalmol. 57:1–14. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chan WH, Biswas S, Ashworth JL and Lloyd
IC: Congenital and infantile cataract: Aetiology and management.
Eur J Pediatr. 171:625–630. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li J, Chen X, Yan Y and Yao K: Molecular
genetics of congenital cataracts. Exp Eye Res. 191:1078722020.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shiels A and Hejtmancik JF: Mutations and
mechanisms in congenital and age-related cataracts. Exp Eye Res.
156:95–102. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Babizhayev MA and Yegorov YE: Reactive
oxygen species and the aging eye: Specific role of metabolically
active mitochondria in maintaining lens function and in the
initiation of the Oxidation-induced maturity onset Cataract-A novel
platform of Mitochondria-targeted antioxidants with broad
therapeutic potential for redox regulation and detoxification of
oxidants in eye diseases. Am J Ther. 23:e98–e117. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bohm EW, Buonfiglio F, Voigt AM, Bachmann
P, Safi T, Pfeiffer N and Gericke A: Oxidative stress in the eye
and its role in the pathophysiology of ocular diseases. Redox Biol.
68:1029672023. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chandrasekaran A, Idelchik M and Melendez
JA: Redox control of senescence and age-related disease. Redox
Biol. 11:91–102. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Giorgio M, Trinei M, Migliaccio E and
Pelicci PG: Hydrogen peroxide: A metabolic by-product or a common
mediator of ageing signals? Nat Rev Mol Cell Biol. 8:722–728. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang L, Nie Q, Gao M, Yang L, Xiang JW,
Xiao Y, Liu FY, Gong XD, Fu JL, Wang Y, et al: The transcription
factor CREB acts as an important regulator mediating oxidative
stress-induced apoptosis by suppressing αB-crystallin expression.
Aging (Albany NY). 12:13594–13617. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Babizhayev MA and Costa EB: Lipid peroxide
and reactive oxygen species generating systems of the crystalline
lens. Biochim Biophys Acta. 1225:326–337. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Klos-Rola J and Zagorski Z: Peroxidation
of lipids in patients with senile cataract. Klin Oczna.
106:416–418. 2004.(In Polish). PubMed/NCBI
|
|
26
|
Li X, Luo JQ, Liao XQ, Zhang S, Yang LF,
Wu T, Wang L, Xu Q, He BS and Guo Z: Allicin inhibits the growth of
HONE-1 and HNE1 human nasopharyngeal carcinoma cells by inducing
ferroptosis. Neoplasma. 3:243–254. 2024. View Article : Google Scholar
|
|
27
|
Babizhayev MA, Deyev AI, Yermakova VN,
Brikman IV and Bours J: Lipid peroxidation and cataracts:
N-acetylcarnosine as a therapeutic tool to manage age-related
cataracts in human and in canine eyes. Drugs R D. 5:125–139. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Thiagarajan R and Manikandan R:
Antioxidants and cataract. Free Radic Res. 47:337–345. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Brennan LA, McGreal RS and Kantorow M:
Oxidative stress defense and repair systems of the ocular lens.
Front Biosci (Elite Ed). 4:141–155. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Babizhayev MA: Rejuvenation of visual
functions in older adult drivers and drivers with cataract during a
short-term administration of N-acetylcarnosine lubricant eye drops.
Rejuvenation Res. 7:186–198. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Higgins MR, Izadi A and Kaviani M:
Antioxidants and exercise performance: With a focus on vitamin E
and C supplementation. Int J Environ Res Public Health.
17:84522020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jiang H, Yin Y, Wu CR, Liu Y, Guo F, Li M
and Ma L: Dietary vitamin and carotenoid intake and risk of
age-related cataract. Am J Clin Nutr. 109:43–54. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sella R and Afshari NA: Nutritional effect
on age-related cataract formation and progression. Curr Opin
Ophthalmol. 30:63–69. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lim JC, Caballero AM, Braakhuis AJ and
Donaldson PJL: Vitamin C and the lens: New insights into delaying
the onset of cataract. Nutrients. 12:31422020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Senthilkumari S, Talwar B, Dharmalingam K,
Ravindran RD, Jayanthi R, Sundaresan P, Saravanan C, Young IS,
Dangour AD and Fletcher AE: Polymorphisms in sodium-dependent
vitamin C transporter genes and plasma, aqueous humor and lens
nucleus ascorbate concentrations in an ascorbate depleted setting.
Exp Eye Res. 124:24–30. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Reddy GB and Bhat KS: Protection against
UVB inactivation (in vitro) of rat lens enzymes by natural
antioxidants. Mol Cell Biochem. 194:41–45. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bron AJ and Brown NA: Perinuclear lens
retrodots: A role for ascorbate in cataractogenesis. Br J
Ophthalmol. 71:86–95. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Taylor A, Jacques PF, Chylack LJ,
Hankinson SE, Khu PM, Rogers G, Friend J, Tung W, Wolfe JK, Padhye
N and Willett WC: Long-term intake of vitamins and carotenoids and
odds of early age-related cortical and posterior subcapsular lens
opacities. Am J Clin Nutr. 75:540–549. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Garland DL: Ascorbic acid and the eye. Am
J Clin Nutr. 54 (6 Suppl):1198S–1202S. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Varma SD, Kumar S and Richards RD:
Light-induced damage to ocular lens cation pump: Prevention by
vitamin C. Proc Natl Acad Sci USA. 76:3504–3506. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Delamere NA and Tamiya S: Expression,
regulation and function of Na,K-ATPase in the lens. Prog Retin Eye
Res. 23:593–615. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Shang F, Lu M, Dudek E, Reddan J and
Taylor A: Vitamin C and vitamin E restore the resistance of
GSH-depleted lens cells to H2O2. Free Radic Biol Med. 34:521–530.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wu K, Kojima M, Shui YB, Sasaki H and
Sasaki K: Ultraviolet B-induced corneal and lens damage in guinea
pigs on low-ascorbic acid diet. Ophthalmic Res. 36:277–283. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hegde KR and Varma SD: Protective effect
of ascorbate against oxidative stress in the mouse lens. Biochim
Biophys Acta. 1670:12–18. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Devamanoharan PS, Henein M, Morris S,
Ramachandran S, Richards RD and Varma SD: Prevention of selenite
cataract by vitamin C. Exp Eye Res. 52:563–568. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Greiner JV and Glonek T: Adenosine
triphosphate (ATP) and protein aggregation in Age-Related
Vision-Threatening ocular diseases. Metabolites. 13:11002023.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhao W, Devamanoharan PS, Henein M, Ali AH
and Varma SD: Diabetes-induced biochemical changes in rat lens:
Attenuation of cataractogenesis by pyruvate. Diabetes Obes Metab.
2:165–174. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Linklater HA, Dzialoszynski T, McLeod HL,
Sanford SE and Trevithick JR: Modelling cortical cataractogenesis.
XI. Vitamin C reduces gamma-crystallin leakage from lenses in
diabetic rats. Exp Eye Res. 51:241–247. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yang YY, Shi LX, Li JH, Yao LY and Xiang
DX: Piperazine ferulate ameliorates the development of diabetic
nephropathy by regulating endothelial nitric oxide synthase. Mol
Med Rep. 19:2245–2253. 2019.PubMed/NCBI
|
|
50
|
Özkaya D, Naziroğlu M, Armağan A, Demirel
A, Köroglu BK, Çolakoğlu N, Kükner A and Sönmez TT: Dietary vitamin
C and E modulates oxidative stress induced-kidney and lens injury
in diabetic aged male rats through modulating glucose homeostasis
and antioxidant systems. Cell Biochem Funct. 29:287–293. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Simpson GL and Ortwerth BJ: The
non-oxidative degradation of ascorbic acid at physiological
conditions. Biochim Biophys Acta. 1501:12–24. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Bensch KG, Fleming JE and Lohmann W: The
role of ascorbic acid in senile cataract. Proc Natl Acad Sci USA.
82:7193–7196. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Sadowska-Bartosz I and Bartosz G: Effect
of glycation inhibitors on aging and age-related diseases. Mech
Ageing Dev. 160:1–18. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Ahmed N, Thornalley PJ, Dawczynski J,
Franke S, Strobel J, Stein G and Haik GM: Methylglyoxal-derived
hydroimidazolone advanced glycation end-products of human lens
proteins. Invest Ophthalmol Vis Sci. 44:5287–5292. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Koshiishi I, Mamura Y, Liu J and Imanari
T: Degradation of dehydroascorbate to 2,3-diketogulonate in blood
circulation. Biochim Biophys Acta. 1425:209–214. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Fan X, Sell DR, Hao C, Liu S, Wang B,
Wesson DW, Siedlak S, Zhu X, Kavanagh TJ, Harrison FE and Monnier
VM: Vitamin C is a source of oxoaldehyde and glycative stress in
age-related cataract and neurodegenerative diseases. Aging Cell.
19:e131762020. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Prabhakaram M and Ortwerth BJ: The
glycation and cross-linking of isolated lens crystallins by
ascorbic acid. Exp Eye Res. 55:451–459. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Tanito M: Reported evidence of vitamin E
protection against cataract and glaucoma. Free Radic Biol Med.
177:100–119. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Jacques PF, Chylack LJ, McGandy RB and
Hartz SC: Antioxidant status in persons with and without senile
cataract. Arch Ophthalmol. 106:337–340. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Knekt P, Heliovaara M, Rissanen A, Aromaa
A and Aaran RK: Serum antioxidant vitamins and risk of cataract.
BMJ. 305:1392–1394. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Zigler JJ, Bodaness RS, Gery I and
Kinoshita JH: Effects of lipid peroxidation products on the rat
lens in organ culture: A possible mechanism of cataract initiation
in retinal degenerative disease. Arch Biochem Biophys. 225:149–156.
1983. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Creighton MO, Sanwal M, Stewart-DeHaan PJ
and Trevithick JR: Modeling cortical cataractogenesis. V. Steroid
cataracts induced by solumedrol partially prevented by vitamin E in
vitro. Exp Eye Res. 37:65–76. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Ross WM, Creighton MO, Inch WR and
Trevithick JR: Radiation cataract formation diminished by vitamin E
in rat lenses in vitro. Exp Eye Res. 36:645–653. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Lee AY and Chung SS: Contributions of
polyol pathway to oxidative stress in diabetic cataract. Faseb J.
13:23–30. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Karslioglu I, Ertekin MV, Kocer I, Taysi
S, Sezen O, Gepdiremen A and Balci E: Protective role of
intramuscularly administered vitamin E on the levels of lipid
peroxidation and the activities of antioxidant enzymes in the lens
of rats made cataractous with gamma-irradiation. Eur J Ophthalmol.
14:478–485. 2004. View Article : Google Scholar
|
|
66
|
Costagliola C, Iuliano G, Menzione M,
Apponi-Battini G and Auricchio G: Effect of topical glucocorticoid
administration on the protein and nonprotein sulfhydryl groups of
the rabbit lens. Ophthalmic Res. 19:351–356. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Wang J, Lofgren S, Dong X, Galichanin K
and Soderberg PG: Dose-response relationship for α-tocopherol
prevention of ultraviolet radiation induced cataract in rat. Exp
Eye Res. 93:91–97. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Ayala MN and Soderberg PG: Vitamin E can
protect against ultraviolet radiation-induced cataract in albino
rats. Ophthalmic Res. 36:264–269. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Seth RK and Kharb S: Protective function
of alpha-tocopherol against the process of cataractogenesis in
humans. Ann Nutr Metab. 43:286–289. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Stahl W, Nicolai S, Briviba K, Hanusch M,
Broszeit G, Peters M, Martin HD and Sies H: Biological activities
of natural and synthetic carotenoids: Induction of gap junctional
communication and singlet oxygen quenching. Carcinogenesis.
18:89–92. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Gao S, Qin T, Liu Z, Caceres MA, Ronchi
CF, Chen CY, Yeum KJ, Taylor A, Blumberg JB, Liu Y and Shang F:
Lutein and zeaxanthin supplementation reduces H2O2-induced
oxidative damage in human lens epithelial cells. Mol Vis.
17:3180–3190. 2011.PubMed/NCBI
|
|
72
|
Ma L, Hao ZX, Liu RR, Yu RB, Shi Q and Pan
JP: A dose-response meta-analysis of dietary lutein and zeaxanthin
intake in relation to risk of age-related cataract. Graefes Arch
Clin Exp Ophthalmol. 252:63–70. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Landrum JT and Bone RA: Lutein,
zeaxanthin, and the macular pigment. Arch Biochem Biophys.
385:28–40. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Krinsky NI, Landrum JT and Bone RA:
Biologic mechanisms of the protective role of lutein and zeaxanthin
in the eye. Annu Rev Nutr. 23:171–201. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Babizhayev MA, Vishnyakova KS and Yegorov
YE: Telomere-dependent senescent phenotype of lens epithelial cells
as a biological marker of aging and cataractogenesis: The role of
oxidative stress intensity and specific mechanism of phospholipid
hydroperoxide toxicity in lens and aqueous. Fundam Clin Pharmacol.
25:139–162. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Chitchumroonchokchai C, Bomser JA, Glamm
JE and Failla ML: Xanthophylls and alpha-tocopherol decrease
UVB-induced lipid peroxidation and stress signaling in human lens
epithelial cells. J Nutr. 134:3225–3232. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Peng J, Zheng TT, Liang Y, Duan LF, Zhang
YD, Wang LJ, He GM and Xiao HT: P-Coumaric acid protects human lens
epithelial cells against oxidative Stress-Induced apoptosis by MAPK
signaling. Oxid Med Cell Longev. 2018:85490522018. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Kinoshita S, Sugawa H, Nanri T, Ohno RI,
Shirakawa JI, Sato H, Katsuta N, Sakake S and Nagai R: Trapa
bispinosa Roxb. And lutein ameliorate cataract in type 1 diabetic
rats. J Clin Biochem Nutr. 66:8–14. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Arnal E, Miranda M, Almansa I, Muriach M,
Barcia JM, Romero FJ, Diaz-Llopis M and Bosch-Morell F: Lutein
prevents cataract development and progression in diabetic rats.
Graefes Arch Clin Exp Ophthalmol. 247:115–120. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Age-Related Eye Disease Study 2 (AREDS2)
Research Group, . Chew EY, SanGiovanni JP, Ferris FL, Wong WT,
Agron E, Clemons TE, Sperduto R, Danis R, Chandra SR, et al:
Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2
randomized trial report no. 4. JAMA Ophthalmol. 131:843–850. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Hu Y and Xu Z: Effects of lutein on the
growth and migration of bovine lens epithelial cells in vitro. J
Huazhong Univ Sci Technolog Med Sci. 28:360–363. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Li AN, Li S, Zhang YJ, Xu XR, Chen YM and
Li HB: Resources and biological activities of natural polyphenols.
Nutrients. 6:6020–6047. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Higuchi A, Yonemitsu K, Koreeda A and
Tsunenari S: Inhibitory activity of epigallocatechin gallate (EGCg)
in paraquat-induced microsomal lipid peroxidation-a mechanism of
protective effects of EGCg against paraquat toxicity. Toxicology.
183:143–149. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Yao K, Ye P, Zhang L, Tan J, Tang X and
Zhang Y: Epigallocatechin gallate protects against oxidative
stress-induced mitochondria-dependent apoptosis in human lens
epithelial cells. Mol Vis. 14:217–223. 2008.PubMed/NCBI
|
|
85
|
Wu Q, Li Z, Lu X, Song J, Wang H, Liu D
and Bi H: Epigallocatechin gallate protects the human lens
epithelial cell survival against UVB irradiation through AIF/endo G
signalling pathways in vitro. Cutan Ocul Toxicol. 40:187–197. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Ghosh D, Agarwal M and Radhakrishna M:
Molecular insights into the inhibitory role of α-Crystallin against
γD-Crystallin aggregation. J Chem Theory Comput. 20:1740–1752.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Kumar V, Gour S, Peter OS, Gandhi S, Goyal
P, Pandey J, Harsolia RS and Yadav JK: Effect of green tea
polyphenol epigallocatechin-3-gallate on the aggregation of
αA(66–80) peptide, a major fragment of αA-crystallin involved in
cataract development. Curr Eye Res. 42:1368–1377. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Chaudhury S, Bag S, Bose M, Das AK, Ghosh
AK and Dasgupta S: Protection of human gammaB-crystallin from
UV-induced damage by epigallocatechin gallate: Spectroscopic and
docking studies. Mol Biosyst. 12:2901–2909. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Ye P, Lin K, Li Z, Liu J, Yao K and Xu W:
(−)-Epigallocatechin gallate regulates expression of apoptotic
genes and protects cultured human lens epithelial cells under
hyperglycemia. Mol Biol (Mosk). 47:251–257. 2013.(In Russian).
View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Caesary AG, Handayani N and Sujuti H:
Effect of epigallocatechin gallate in green tea on preventing lens
opacity and αB-crystallin aggregation in rat model of diabetes. Int
J Ophthalmol. 16:342–347. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Zhang Z, Zhang X, Bi K, He Y, Yan W, Yang
C and Zhang J: Potential protective mechanisms of green tea
polyphenol EGCG against COVID-19. Trends Food Sci Technol.
114:11–24. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Huang W, Li S, Zeng J, Liu Y, Wu M and
Zhang M: Growth inhibition, induction of apoptosis by green tea
constituent (−)-epigallocatechin-3-gallate in cultured rabbit lens
epithelial cells. Yan Ke Xue Bao. 16:194–198. 2000.PubMed/NCBI
|
|
93
|
Huang W, Liu Y, Zeng J and Wu M: Role of
p38MAPKs pathway in the growth inhibition of rabbit lens epithelial
cells induced by EGCG. Yan Ke Xue Bao. 19:236–238. 2472003.(In
Chinese). PubMed/NCBI
|
|
94
|
Zhou DD, Luo M, Huang SY, Saimaiti A,
Shang A, Gan RY and Li HB: Effects and mechanisms of resveratrol on
aging and Age-related diseases. Oxid Med Cell Longev.
2021:99322182021. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Bryl A, Falkowski M, Zorena K and Mrugacz
M: The role of resveratrol in eye Diseases-A review of the
literature. Nutrients. 14:29742022. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Zheng Y, Liu Y, Ge J, Wang X, Liu L, Bu Z
and Liu P: Resveratrol protects human lens epithelial cells against
H2O2-induced oxidative stress by increasing catalase, SOD-1, and
HO-1 expression. Mol Vis. 16:1467–1474. 2010.PubMed/NCBI
|
|
97
|
Chen P, Yao Z and He Z: Resveratrol
protects against high glucose-induced oxidative damage in human
lens epithelial cells by activating autophagy. Exp Ther Med.
21:4402021. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Ran H, Liu H and Wu P: Echinatin mitigates
H2O2-induced oxidative damage and apoptosis in lens epithelial
cells via the Nrf2/HO-1 pathway. Adv Clin Exp Med. 30:1195–1203.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Li J, Huang Y, Ma T, Liu Y, Luo Y, Gao L,
Li Z and Ye Z: Carbon monoxide releasing molecule-3 alleviates
oxidative stress and apoptosis in Selenite-induced cataract in rats
via activating Nrf2/HO-1 pathway. Curr Eye Res. 48:919–929. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Chen J, Li X, Liu H, Zhong D, Yin K, Li Y,
Zhu L, Xu C, Li M and Wang C: Bone marrow stromal cell-derived
exosomal circular RNA improves diabetic foot ulcer wound healing by
activating the nuclear factor erythroid 2-related factor 2 pathway
and inhibiting ferroptosis. Diabet Med. 40:e150312023. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Dai Z, Zhu B, Yu H, Jian X, Peng J, Fang C
and Wu Y: Role of autophagy induced by arecoline in angiogenesis of
oral submucous fibrosis. Arch Oral Biol. 102:7–15. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Li F, Li D, Liu H, Cao BB, Jiang F, Chen
DN and Li JD: RNF216 regulates the migration of immortalized GnRH
neurons by suppressing Beclin1-mediated autophagy. Front Endocrinol
(Lausanne). 10:122019. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Luo G, Zhou Z, Huang C, Zhang P, Sun N,
Chen W, Deng C, Li X, Wu P, Tang J and Qing L: Itaconic acid
induces angiogenesis and suppresses apoptosis via Nrf2/autophagy to
prolong the survival of multi-territory perforator flaps. Heliyon.
9:e179092023. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Jegal KH, Ko HL, Park SM, Byun SH, Kang
KW, Cho IJ and Kim SC: Eupatilin induces Sestrin2-dependent
autophagy to prevent oxidative stress. Apoptosis. 21:642–656. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Barlow AD and Thomas DC: Autophagy in
diabetes: β-cell dysfunction, insulin resistance, and
complications. Dna Cell Biol. 34:252–260. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Singh A and Bodakhe SH: Biochemical
evidence indicates the preventive effect of resveratrol and
nicotinamide in the treatment of STZ-induced diabetic cataract.
Curr Eye Res. 46:52–63. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Higashi Y, Higashi K, Mori A, Sakamoto K,
Ishii K and Nakahara T: Anti-cataract effect of resveratrol in
High-Glucose-Treated Streptozotocin-Induced diabetic rats. Biol
Pharm Bull. 41:1586–1592. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Chen Q, Gu P, Liu X, Hu S, Zheng H, Liu T
and Li C: Gold nanoparticles encapsulated resveratrol as an
Anti-Aging agent to delay cataract development. Pharmaceuticals
(Basel). 16:262022. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Smith A, Eldred JA and Wormstone IM:
Resveratrol inhibits wound healing and lens fibrosis: A putative
candidate for posterior capsule opacification prevention. Invest
Ophthalmol Vis Sci. 60:3863–3877. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Vasey C, McBride J and Penta K: Circadian
rhythm dysregulation and restoration: The role of melatonin.
Nutrients. 13:34802021. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Wang L, Xu S, Chen R, Ding Y, Liu M, Hou
C, Wu Z, Men X, Bao M, He B and Li S: Exploring the causal
association between epigenetic clocks and menopause age: Insights
from a bidirectional Mendelian randomization study. Front
Endocrinol (Lausanne). 15:14295142024. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Abe M, Reiter RJ, Orhii PB, Hara M and
Poeggeler B: Inhibitory effect of melatonin on cataract formation
in newborn rats: Evidence for an antioxidative role for melatonin.
J Pineal Res. 17:94–100. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Crooke A, Huete-Toral F, Colligris B and
Pintor J: The role and therapeutic potential of melatonin in
age-related ocular diseases. J Pineal Res. 632017.doi:
10.1111/jpi.12430. PubMed/NCBI
|
|
114
|
Bai J, Dong L, Song Z, Ge H, Cai X, Wang G
and Liu P: The role of melatonin as an antioxidant in human lens
epithelial cells. Free Radic Res. 47:635–642. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Mi Y, Wei C, Sun L, Liu H, Zhang J, Luo J,
Yu X, He J, Ge H and Liu P: Melatonin inhibits ferroptosis and
delays age-related cataract by regulating SIRT6/p-Nrf2/GPX4 and
SIRT6/NCOA4/FTH1 pathways. Biomed Pharmacother. 157:1140482023.
View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Sun Z, Zou X, Bao M, Huang Z, Lou Y, Zhang
Y and Huang P: Role of ferroptosis in fibrosis diseases. Am J Med
Sci. 366:87–95. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Liu Y, Li H and Liu Y: MicroRNA-378a
regulates the reactive oxygen species (ROS)/Phosphatidylinositol
3-Kinases (PI3K)/AKT signaling pathway in human lens epithelial
cells and cataract. Med Sci Monit. 25:4314–4321. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Khorsand M, Akmali M, Sharzad S and
Beheshtitabar M: Melatonin reduces cataract formation and aldose
reductase activity in lenses of streptozotocin-induced diabetic
rat. Iran J Med Sci. 41:305–313. 2016.PubMed/NCBI
|
|
119
|
Jedziniak JA, Chylack LJ, Cheng HM, Gillis
MK, Kalustian AA and Tung WH: The sorbitol pathway in the human
lens: Aldose reductase and polyol dehydrogenase. Invest Ophthalmol
Vis Sci. 20:314–326. 1981.PubMed/NCBI
|
|
120
|
Mi W, Xia Y and Bian Y: Meta-analysis of
the association between aldose reductase gene (CA)n microsatellite
variants and risk of diabetic retinopathy. Exp Ther Med.
18:4499–4509. 2019.PubMed/NCBI
|
|
121
|
Kiziltoprak H, Tekin K, Inanc M and Goker
YS: Cataract in diabetes mellitus. World J Diabetes. 10:140–153.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Karslioglu I, Ertekin MV, Taysi S, Kocer
I, Sezen O, Gepdiremen A, Koç M and Bakan N: Radioprotective
effects of melatonin on radiation-induced cataract. J Radiat Res.
46:277–282. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Varma SD, Hegde KR and Kovtun S:
UV-B-induced damage to the lens in vitro: Prevention by caffeine. J
Ocul Pharmacol Ther. 24:439–444. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Varma SD, Hegde KR and Kovtun S:
Inhibition of selenite-induced cataract by caffeine. Acta
Ophthalmol. 88:e245–e249. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Varma SD and Kovtun S: Protective effect
of caffeine against high sugar-induced transcription of microRNAs
and consequent gene silencing: A study using lenses of galactosemic
mice. Mol Vis. 19:493–500. 2013.PubMed/NCBI
|
|
126
|
Kronschlager M, Ruiss M, Dechat T and
Findl O: Single high-dose peroral caffeine intake inhibits
ultraviolet radiation-induced apoptosis in human lens epithelial
cells in vitro. Acta Ophthalmol. 99:e587–e593. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Devasagayam TP, Kamat JP, Mohan H and
Kesavan PC: Caffeine as an antioxidant: Inhibition of lipid
peroxidation induced by reactive oxygen species. Biochim Biophys
Acta. 1282:63–70. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Nakazawa Y, Ishimori N, Oguchi J, Nagai N,
Kimura M, Funakoshi-Tago M and Tamura H: Coffee brew intake can
prevent the reduction of lens glutathione and ascorbic acid levels
in HFD-fed animals. Exp Ther Med. 17:1420–1425. 2019.PubMed/NCBI
|
|
129
|
Luo J, Wang L, Cui C, Chen H, Zeng W and
Li X: MicroRNA-19a-3p inhibits endothelial dysfunction in
atherosclerosis by targeting JCAD. BMC Cardiovasc Disor.
24:3942024. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Evereklioglu C, Guldur E, Alasehirli B,
Cengiz B, Sari I and Pirbudak L: Excessive maternal caffeine
exposure during pregnancy is cataractogenic for neonatal
crystalline lenses in rats: A biomicroscopic and histopathologic
study. Acta Ophthalmol Scand. 82:552–556. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Babizhayev MA, Yermakova VN, Sakina NL,
Evstigneeva RP, Rozhkova EA and Zheltukhina GA: N
alpha-acetylcarnosine is a prodrug of L-carnosine in ophthalmic
application as antioxidant. Clin Chim Acta. 254:1–21. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Babizhayev MA, Micans P, Guiotto A and
Kasus-Jacobi A: N-acetylcarnosine lubricant eyedrops possess
all-in-one universal antioxidant protective effects of L-carnosine
in aqueous and lipid membrane environments, aldehyde scavenging,
and transglycation activities inherent to cataracts: A clinical
study of the new vision-saving drug N-acetylcarnosine eyedrop
therapy in a database population of over 50,500 patients. Am J
Ther. 16:517–533. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Babizhayev MA, Guiotto A and Kasus-Jacobi
A: N-Acetylcarnosine and histidyl-hydrazide are potent agents for
multitargeted ophthalmic therapy of senile cataracts and diabetic
ocular complications. J Drug Target. 17:36–63. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Xiong T, Li Z, Huang X, Lu K, Xie W, Zhou
Z and Tu J: TO901317 inhibits the development of hepatocellular
carcinoma by LXRalpha/Glut1 decreasing glycometabolism. Am J
Physiol Gastrointest Liver Physiol. 316:G598–G607. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Fan X and Monnier VM: Protein
posttranslational modification (PTM) by glycation: Role in lens
aging and age-related cataractogenesis. Exp Eye Res.
210:1087052021. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Babizhayev MA and Yegorov YE: Telomere
attrition in lens epithelial cells-a target for N-acetylcarnosine
therapy. Front Biosci (Landmark Ed). 15:934–956. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Babizhayev MA: Analysis of lipid
peroxidation and electron microscopic survey of maturation stages
during human cataractogenesis: Pharmacokinetic assay of Can-C
N-acetylcarnosine prodrug lubricant eye drops for cataract
prevention. Drugs R D. 6:345–369. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Jain AK, Lim G, Langford M and Jain SK:
Effect of high-glucose levels on protein oxidation in cultured lens
cells, and in crystalline and albumin solution and its inhibition
by vitamin B6 and N-acetylcysteine: Its possible relevance to
cataract formation in diabetes. Free Radic Biol Med. 33:1615–1621.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Zhang S, Chai FY, Yan H, Guo Y and Harding
JJ: Effects of N-acetylcysteine and glutathione ethyl ester drops
on streptozotocin-induced diabetic cataract in rats. Mol Vis.
14:862–870. 2008.PubMed/NCBI
|
|
140
|
Tuzcu EA, Tuzcu K, Basarslan F, Motor S,
Coskun M, Keskin U, Ayintap E, Ilhan O and Oksuz H: Protective
effects of N-acetylcysteine on triamcinolone acetonide-induced lens
damage in rats. Cutan Ocul Toxicol. 33:294–298. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Aydin B, Yagci R, Yilmaz FM, Erdurmus M,
Karadag R, Keskin U, Durmus M and Yigitoglu R: Prevention of
selenite-induced cataractogenesis by N-acetylcysteine in rats. Curr
Eye Res. 34:196–201. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Wang P, Liu XC, Yan H and Li MY:
Hyperoxia-induced lens damage in rabbit: Protective effects of
N-acetylcysteine. Mol Vis. 15:2945–2952. 2009.PubMed/NCBI
|
|
143
|
Erol G, Kartal H, Comu FM, Cetin E,
Demirdas E, Sicim H, Unal CS, Gunay C, Oz BS and Bolcal C: Effects
of N-Acetylcysteine and N-Acetylcysteine amide on erythrocyte
deformability and oxidative stress in a rat model of lower
extremity Ischemia-Reperfusion injury. Cardiol Res Pract.
2020:68418352020. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Martis RM, Grey AC, Wu H, Wall GM,
Donaldson PJ and Lim JC: N-Acetylcysteine amide (NACA) and diNACA
inhibit H2O2-induced cataract formation ex
vivo in pig and rat lenses. Exp Eye Res. 234:1096102023. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Maddirala Y, Tobwala S, Karacal H and
Ercal N: Prevention and reversal of selenite-induced cataracts by
N-acetylcysteine amide in Wistar rats. BMC Ophthalmol. 17:542017.
View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Carey JW, Pinarci EY, Penugonda S, Karacal
H and Ercal N: In vivo inhibition of
l-buthionine-(S,R)-sulfoximine-induced cataracts by a novel
antioxidant, N-acetylcysteine amide. Free Radic Biol Med.
50:722–729. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Moreau KL and King JA: Protein misfolding
and aggregation in cataract disease and prospects for prevention.
Trends Mol Med. 18:273–282. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Cvekl A, McGreal R and Liu W: Lens
development and crystallin gene expression. Prog Mol Biol Transl
Sci. 134:129–167. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Zhao L, Chen XJ, Zhu J, Xi YB, Yang X, Hu
LD, Ouyang H, Patel SH, Jin X, Lin D, et al: Lanosterol reverses
protein aggregation in cataracts. Nature. 523:607–611. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Zhang K, He W, Du Y, Zhou Y, Wu X, Zhu J,
Zhu X, Zhang K and Lu Y: Inhibitory effect of lanosterol on
cataractous lens of cynomolgus monkeys using a subconjunctival drug
release system. Precis Clin Med. 5:pbac0212022. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Deguchi S, Kadowaki R, Otake H, Taga A,
Nakazawa Y, Misra M, Yamamoto N, Sasaki H and Nagai N: Combination
of lanosterol and nilvadipine nanosuspensions rescues lens
opacification in Selenite-Induced cataractic rats. Pharmaceutics.
14:15202022. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Sweeney MH and Truscott RJ: An impediment
to glutathione diffusion in older normal human lenses: A possible
precondition for nuclear cataract. Exp Eye Res. 67:587–595. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Nagai N, Fukuoka Y, Sato K, Otake H, Taga
A, Oka M, Hiramatsu N and Yamamoto N: The intravitreal injection of
lanosterol nanoparticles rescues lens structure collapse at an
early stage in shumiya cataract rats. Int J Mol Sci. 21:10482020.
View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Hua H, Yang T, Huang L, Chen R, Li M, Zou
Z, Wang N, Yang D and Liu Y: Protective effects of lanosterol
synthase Up-regulation in UV-B-induced oxidative stress. Front
Pharmacol. 10:9472019. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Shen X, Zhu M, Kang L, Tu Y, Li L, Zhang
R, Qin B, Yang M and Guan H: Lanosterol synthase pathway alleviates
lens opacity in Age-related cortical cataract. J Ophthalmol.
2018:41258932018. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Chen XJ, Hu LD, Yao K and Yan YB:
Lanosterol and 25-hydroxycholesterol dissociate crystallin
aggregates isolated from cataractous human lens via different
mechanisms. Biochem Biophys Res Commun. 506:868–873. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Kang H, Yang Z and Zhou R: Lanosterol
disrupts aggregation of human gammaD-Crystallin by binding to the
hydrophobic dimerization interface. J Am Chem Soc. 140:8479–8486.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Makley LN, McMenimen KA, DeVree BT,
Goldman JW, McGlasson BN, Rajagopal P, Dunyak BM, McQuade TJ,
Thompson AD, Sunahara R, et al: Pharmacological chaperone for
α-crystallin partially restores transparency in cataract models.
Science. 350:674–677. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Molnar KS, Dunyak BM, Su B, Izrayelit Y,
McGlasson-Naumann B, Hamilton PD, Qian M, Covey DF, Gestwicki JE,
Makley LN and Andley UP: Mechanism of action of VP1-001 in
cryAB(R120G)-Associated and Age-Related cataracts. Invest
Ophthalmol Vis Sci. 60:3320–3331. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Daszynski DM, Santhoshkumar P, Phadte AS,
Sharma KK, Zhong HA, Lou MF and Kador PF: Failure of oxysterols
such as lanosterol to restore lens clarity from cataracts. Sci Rep.
9:84592019. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Shanmugam PM, Barigali A, Kadaskar J,
Borgohain S, Mishra DK, Ramanjulu R and Minija CK: Effect of
lanosterol on human cataract nucleus. Indian J Ophthalmol.
63:888–890. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Raju M, Santhoshkumar P and Krishna SK:
Alpha-crystallin-derived peptides as therapeutic chaperones.
Biochim Biophys Acta. 1860:246–251. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Budnar P, Tangirala R, Bakthisaran R and
Rao CM: Protein aggregation and cataract: Role of Age-related
modifications and mutations in α-Crystallins. Biochemistry (Mosc).
87:225–241. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Sprague-Piercy MA, Rocha MA, Kwok AO and
Martin RW: α-Crystallins in the vertebrate eye lens: Complex
oligomers and molecular chaperones. Annu Rev Phys Chem. 72:143–163.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Wang T, Yao J, Jia L, Fort PE and Zacks
DN: Loss of alphaA or alphaB-Crystallin accelerates photoreceptor
cell death in a mouse model of P23H autosomal dominant retinitis
pigmentosa. Int J Mol Sci. 23:702021. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Joachim SC, Bruns K, Lackner KJ, Pfeiffer
N and Grus FH: Analysis of IgG antibody patterns against retinal
antigens and antibodies to alpha-crystallin, GFAP, and
alpha-enolase in sera of patients with ‘wet’ age-related macular
degeneration. Graefes Arch Clin Exp Ophthalmol. 245:619–626. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Sharma KK, Kumar RS, Kumar GS and Quinn
PT: Synthesis and characterization of a peptide identified as a
functional element in alphaA-crystallin. J Biol Chem.
275:3767–3771. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Bhattacharyya J, Padmanabha UE, Wang J and
Sharma KK: Mini-alphaB-crystallin: A functional element of
alphaB-crystallin with chaperone-like activity. Biochemistry.
45:3069–3076. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Nahomi RB, Wang B, Raghavan CT, Voss O,
Doseff AI, Santhoshkumar P and Nagaraj RH: Chaperone peptides of
α-crystallin inhibit epithelial cell apoptosis, protein
insolubilization, and opacification in experimental cataracts. J
Biol Chem. 288:13022–13035. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Raju M, Santhoshkumar P and Sharma KK:
AlphaA-Crystallin-derived mini-chaperone modulates stability and
function of cataract causing alphaAG98R-crystallin. PLoS One.
7:e440772012. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Ghosh KS, Pande A and Pande J: Binding of
γ-crystallin substrate prevents the binding of copper and zinc ions
to the molecular chaperone α-crystallin. Biochemistry.
50:3279–3281. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Banerjee PR, Pande A, Shekhtman A and
Pande J: Molecular mechanism of the chaperone function of
mini-α-crystallin, a 19-residue peptide of human α-crystallin.
Biochemistry. 54:505–515. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Chemerovski-Glikman M, Mimouni M, Dagan Y,
Haj E, Vainer I, Allon R, Blumenthal EZ, Adler-Abramovich L, Segal
D, Gazit E and Zayit-Soudry S: Rosmarinic acid restores complete
transparency of sonicated human cataract ex vivo and delays
cataract formation in vivo. Sci Rep. 8:93412018. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Zych M, Wojnar W, Dudek S and
Kaczmarczyk-Sedlak I: Rosmarinic and sinapic acids may increase the
content of reduced glutathione in the lenses of Estrogen-Deficient
rats. Nutrients. 11:8032019. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Tsai CF, Wu JY and Hsu YW: Protective
effects of rosmarinic acid against Selenite-induced cataract and
oxidative damage in rats. Int J Med Sci. 16:729–740. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Babizhayev MA and Yegorov YE: Telomere
attrition in human lens epithelial cells associated with oxidative
stress provide a new therapeutic target for the treatment,
dissolving and prevention of cataract with N-Acetylcarnosine
lubricant eye drops. Kinetic, pharmacological and
Activity-dependent separation of therapeutic targeting:
Transcorneal penetration and delivery of L-Carnosine in the aqueous
humor and Hormone-Like hypothalamic antiaging effects of the
instilled ophthalmic drug through a safe eye medication technique.
Recent Pat Drug Deliv Formul. 10:82–129. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Kumar B and Reilly MA: The development,
growth, and regeneration of the crystalline lens: A review. Curr
Eye Res. 45:313–326. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Cetinel S and Montemagno C: Nanotechnology
for the prevention and treatment of cataract. Asia Pac J Ophthalmol
(Phila). 4:381–387. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Lee BJ and Afshari NA: Advances in drug
therapy and delivery for cataract treatment. Curr Opin Ophthalmol.
34:3–8. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Marco-Benedi V, Laclaustra M,
Sanchez-Hernandez RM, Ortega-Martinez DVE, Pedro-Botet J, Puzo J
and Civeira F: Cataract surgery in elderly subjects with
heterozygous familial hypercholesterolemia in prolonged treatment
with statins. J Clin Med. 10:34942021. View Article : Google Scholar : PubMed/NCBI
|
